10 Best Vaccine Stocks to Buy Now The mass COVID-19 vaccination drive has sent the stocks of publicly traded firms developing the vaccine into overdrive. In addition to the big pharma giants, there are some smaller companies along the vaccine supply chain that also stand to gain from the soaring prices. Bank of America analysts last year underlined how the firms making syringes used to inject vaccines could witness explosive growth, as well as those who planned to distribute the vaccine in the hundreds of millions across the European heartland and Asia. Growth Catalysts for Vaccine Stocks A research report published by Market Study at the end of last month found that the global COVID-19 vaccine market was expected to touch more than $25 billion in worth within the next three years. Industry experts cited in the study detailed that North American firms were expected to lead the market in this regard, with European and Asian firms following close behind. Market Study claimed that new outbreaks of the virus and increased governmental purchases of the vaccine were driving the positive market forecast.